Skip to content

HPLC analysis published for every batchTHC < 0.3%Shipped from France10% off when you sign up

JWH-030

Synthetic cannabinoid of the JWH series, CB1 agonist in animal tissue, classified as a narcotic in France.

C₂₀H₂₁NO

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

Data sheet

Names

IUPAC name
naphthalen-1-yl-(1-pentylpyrrol-3-yl)methanone
Other names
Naphthalen-1-yl(1-pentyl-1H-pyrrol-3-yl)methanone · 1-naphthalenyl(1-pentyl-1h-pyrrol-3-yl)methanone · Naphthalen-1-yl-(1-pentylpyrrol-3-yl)methanone

Identifiers

Formula
C₂₀H₂₁NO
Molar mass
291.40 g/mol
CAS
162934-73-8
PubChem CID
9971539(new tab)
InChIKey
VPBJQDBKZSHCPC-UHFFFAOYSA-N

Class

Family
Synthetic cannabinoid (SCRA)

Legal status

France
Narcotic: named in schedule
International
Unscheduled
See the legal framework

Updated on

Receptors and activity

  1. CB1Agonist88 out of 100

    CI50 3,38 nM sur le déférent de souris (Pertwee et coll., 1995) ; valeur fonctionnelle, aucune constante Ki vérifiée dans les sources consultées

Bar length shows the relative strength of the interaction, as an indication.

Subjective signature

Calm
5 out of 100
Relaxation of body and mind; reduced mental noise without marked drowsiness.
Clarity
5 out of 100
Sustained attention and clear thinking; functional lucidity, not euphoria.
High
10 out of 100
Euphoria and sensory intensity; altered perception of time and space.
Appetite
15 out of 100
Stimulation of hunger and of taste appreciation (the “munchies” effect).
Sleep
10 out of 100
Sedative effect: aids sleep onset and the continuity of deep sleep.
Editorial estimate, not clinical.

Pharmacology

JWH-030, or naphthalen-1-yl-(1-pentylpyrrol-3-yl)methanone, is a synthetic cannabinoid of the JWH series belonging to the naphthoylpyrroles. It is the pyrrole analogue of JWH-018, whose indole ring is replaced by a pyrrole. On the mouse vas deferens, it inhibits electrically evoked contractions with an IC50 of 3.38 nM, placing it close to JWH-007 (2.56 nM), and its effect is antagonized by SR141716A (Pertwee et al., 1995). The available safety data remain preliminary: it prolongs the QT interval in rats and blocks the hERG channel with an IC50 of 88.36 µM (Yun et al., 2016). No clinical human data are published in the sources consulted.

History

Source
Synthetic molecule, described as such in the sources consulted. It has been detected in illicit products in Japan, where it is one of a dozen synthetic cannabinoids reported as newly distributed designer drugs (Uchiyama et al., 2013).

Origin (pharmaceutical research → illicit market)

No biosynthetic pathway: JWH-030 is produced by no living organism and belongs to no hemp chemotype. It belongs to synthetic chemistry alone: a pyrrole carries on its nitrogen a pentyl chain and, at position 3, a carbonyl group linking it to a naphthalene ring.

References

Structured data

SMILES
CCCCCN1C=CC(=C1)C(=O)C2=CC=CC3=CC=CC=C32
InChIKey
VPBJQDBKZSHCPC-UHFFFAOYSA-N

Machine-readable entry (JSON)

LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.